Lyell Immunopharma, Inc. (LYEL): Depreciation & Amortization
$11.54M
Year ended 2025-12-31
$9.52M
Trailing 12 months to 2026-06-30
-13.8%
3-year compound annual growth
+21.9%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.54M | -41.2% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $19.63M | -3.1% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $20.25M | +12.4% | 2026-03-12, From 2023-01-01 |
| 2022-12-31 | $18.02M | +32.3% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $13.62M | +217.3% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $4.29M | +241.9% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $1.26M | n/a | 2022-03-29, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $11.54M | -41.2% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $1.15M | +2.3% |
| Talphera, Inc. (TLPH) | 2024-12-31 | $0 | -100.0% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.04M | -12.0% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $344.0K | +103.6% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $704.0K | +6.7% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $20.2K | -1.0% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $246.0K | +138.8% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $173.0K | -12.2% |
Compare LYEL, IBO, TLPH, HCWB side by side · Screen every company in Pharmaceutical Preparations ↗